Ryan Cross is an Associated editor at Chemical & Engineering news since 2017. He studied neuroscience and genetics at Purdue University, and earned an M.S. in science journalism at Boston University. He writes news and feature stories about the scientists, startups, and drug companies trying to turn the latest biomedical discoveries into medicines.

He is particularly interested in biotech and pharmaceutical industries, drug discovery, gene editing, synthetic biology, bioethics, CRISPR, genetic engineering, neuropharmacology, new drug modalities, and emerging scientific fields.